Literature DB >> 23470255

Study on the distribution sites and the molecular mechanism of analgesia after intracerebroventricular injection of rat/mouse hemokinin-1 in mice.

Rui-Long Xia1, Cai-Yun Fu, Shi-Fu Zhang, Yuan-Ting Jin, Fu-Kun Zhao.   

Abstract

Hemokinin-1 is a peptide encoded by Pptc, which belongs to the family of mammalian tachykinins. Our previous results showed that rat/mouse hemokinin-1 (r/m HK-1) produced striking analgesia after intracerebroventricular (i.c.v.) injection in mice, and the analgesia could be blocked by the NK1 receptor antagonist and the opioid receptor antagonist, respectively. However, the precise distribution sites and the molecular mechanism involved in the analgesic effect after i.c.v. administration of r/m HK-1 are needed to be further investigated deeply. Using the fluorescence labeling method, our present results directly showed that r/m HK-1 peptides were mainly distributed at the ventricular walls and several juxta-ventricular structures for the first time. Our results showed that the mRNA expressions of NK1 receptor, PPT-A, PPT-C, KOR, PDYN, DOR and PENK were not changed markedly, as well as the protein expression of NK1 receptor was hardly changed. However, both the transcripts and proteins of MOR and POMC were up-regulated significantly, indicating that the analgesic effect induced by i.c.v. administration of r/m HK-1 is related to the activation of NK1 receptor first, then it is related to the release of endogenous proopiomelanocortin, as well as the increased expression level of μ opioid receptor. These results should facilitate further the analysis of the analgesia of r/m HK-1 in the central nerval system in acute pain and may open novel pharmacological interventions. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470255     DOI: 10.1016/j.peptides.2013.02.020

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Mouse Hemokinin-1 Decapeptide Subjected to a Brain-specific Post-translational Modification.

Authors:  Georgia Deliconstantinos; Stephen Barton; Mikhail Soloviev; Nigel Page
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

2.  Hemokinin-1(4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice.

Authors:  Cai-Yun Fu; Rui-Long Xia; Teng-Fei Zhang; Yan Lu; Shi-Fu Zhang; Zhi-Qiang Yu; Tao Jin; Xiao-Zhou Mou
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

3.  A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.

Authors:  Yu Zou; Chuan-Gen Guo; Zheng-Gang Yang; Jun-Hui Sun; Min-Ming Zhang; Cai-Yun Fu
Journal:  Drug Des Devel Ther       Date:  2016-03-24       Impact factor: 4.162

4.  Hemokinin-1 Gene Expression Is Upregulated in Trigeminal Ganglia in an Inflammatory Orofacial Pain Model: Potential Role in Peripheral Sensitization.

Authors:  Timea Aczél; Angéla Kecskés; József Kun; Kálmán Szenthe; Ferenc Bánáti; Susan Szathmary; Róbert Herczeg; Péter Urbán; Attila Gyenesei; Balázs Gaszner; Zsuzsanna Helyes; Kata Bölcskei
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.